What are the breastfeeding precautions for remimazolam besylate?

Remimazolam besylate should be avoided in breastfeeding mothers because infant risk cannot be excluded and human milk excretion is unknown; if administration is necessary, breastfeeding should be discontinued for 24 hours afterward.